TITLE

T-SPOT.TB responses during treatment of pulmonary tuberculosis

AUTHOR(S)
Ribeiro, Samantha; Dooley, Kelly; Hackman, Judith; Loredo, Carla; Efron, Anne; Chaisson, Richard E.; Conde, Marcus B.; Boechat, Neio; Dorman, Susan E.
PUB. DATE
January 2009
SOURCE
BMC Infectious Diseases;2009, Vol. 9 Issue 1, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Immune responses to Mycobacterium tuberculosis antigens could serve as surrogate markers of treatment response. Methods: Using the T-SPOT.TB assay and frozen peripheral blood mononuclear cells, we enumerated ESAT-6- and CFP-10-specific IFN-γ-producing T cells over time in pulmonary TB patients receiving directly observed treatment. T cell responses (measured as "spot forming cells" or "SFCs") were assessed prior to treatment and at 16 and 24 weeks of treatment. Results: 58 patients were evaluated, of whom 57 were HIV seronegative. Mean (SD) ESAT-6, CFP-10, and summed RD1 specific SFCs declined from 42.7 (72.7), 41.2 (66.4), and 83.8 (105.7) at baseline to 23.3 (39.4, p = 0.01), 23.2 (29.4, p = 0.18), and 46.5 (59.5, p = 0.02) at completion of 24 weeks of treatment, respectively. Only 10% of individuals with a baseline reactive test reverted to negative at treatment week 24. For the group that was culture positive at completion of 8 weeks of treatment compared to the culture negative group, the incidence rate ratio (IRR) of ESAT-6, CFP-10, and summed RD1 specific SFC counts were, respectively, 2.23 (p = 0.048), 1.51 (p = 0.20), and 1.83 (p = 0.047). Patients with cavitary disease had mean ESAT-6 specific SFC counts that were higher than those without cavitary disease (IRR 2.08, p = 0.034). Conclusion: IFN-γ-producing RD1-specific T cells, as measured in the T-SPOT.TB assay, may be directly related to bacterial load in patients undergoing treatment for pulmonary TB. However, high inter-subject variability in quantitative results coupled with failure of reversion to negative of qualitative results in most subjects at treatment completion may limit the utility of this assay as a surrogate marker for treatment efficacy.
ACCESSION #
42634154

 

Related Articles

  • Reinfection with Mycobacterium tuberculosis after Treatment: Canada and the United States. Deresinski, Stan // Clinical Infectious Diseases;4/1/2005, Vol. 40 Issue 7, preceding p915 

    This article focuses on reinfection with mycobacterium tuberculosis after treatment. An accurate estimate of the proportion of cases due to reinfection in Canada and the United States, where the annual incidence of TB is !6 cases per 100,000 population, has previously been lacking. The...

  • Progression to Active Tuberculosis, but Not Transmission, Varies by Mycobacterium tuberculosis Lineage in The Gambia. de Jong, Bouke C.; Hill, Philip C.; Aiken, Alex; Awine, Timothy; Antonio, Martin; Adetifa, Ifedayo M.; Jackson-Sillah, Dolly J.; Fox, Annette; DeRiemer, Kathryn; Gagneux, Sebastien; Borgdorff, Martien W.; McAdam, Keith P. W. J.; Corrah, Tumani; Small, Peter M.; Adegbola, Richard A. // Journal of Infectious Diseases;10/1/2008, Vol. 198 Issue 7, p1037 

    Background. There is considerable variability in the outcome of Mycobacterium tuberculosis infection. We hypothesized that Mycobacterium africanum was less likely than M. tuberculosis to transmit and progress to tuberculosis disease. Methods. In a cohort study of patients with tuberculosis and...

  • Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. Talati, Naasha J.; Seybold, Ulrich; Humphrey, Bianca; Aina, Abiola; Tapia, Jane; Weinfurter, Paul; Albalak, Rachel; Blumberg, Henry M. // BMC Infectious Diseases;2009, Vol. 9 Issue 1, Special section p1 

    Background: A new generation of diagnostic tests, the interferon-γ release assays (IGRAs), have been developed for the detection of latent tuberculosis infection (LTBI). Limited data are available on their use in HIV-infected persons. Methods: A cross-sectional study was carried out at 2 HIV...

  • Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis. Lahey, Timothy; Matee, Mecky; Mtei, Lillian; Bakari, Muhammad; Pallangyo, Kisali; von Reyn, C. Fordham // BMC Infectious Diseases;2009, Vol. 9 Issue 1, Special section p1 

    Background: Identifying novel TB diagnostics is a major public health priority. We explored the diagnostic characteristics of antimycobacterial lymphocyte proliferation assays (LPA) in HIV-infected subjects with latent or active TB. Methods: HIV-infected subjects with bacille Calmette Guérin...

  • Tuberculous tenosynovitis. Sanders, Clayton J.; Schucany, William G. // Baylor University Medical Center Proceedings;Jan2008, Vol. 21 Issue 1, p71 

    The article provides information related to Mycobacterium tuberculosis. Mycobacterium tuberculosis remain the top-10 cause of death worldwide. Tuberculosis is spread primarily by inhalation of infected droplets, resulting in pulmonary disease. Tuberculous tenosynovitis is a rare complication of...

  • Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. Sun, Yong-Jiang; Lim, T.K.; Ong, Adrian Kheng Yeow; Benjamin Choon Heng Ho; Seah, Geok Teng; Paton, Nicholas I. // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p1 

    Background: The Mycobacterium tuberculosis Beijing genotype is biologically different from other genotypes. We aimed to clinically and immunologically compare human tuberculosis caused by Beijing and non-Beijing strains. Methods: Pulmonary tuberculosis patients were prospectively enrolled and...

  • Tuberculoma of the liver. Bharathi, A.; Nagarjuna, K.; Prasad, G. V. S. N.; Reddy, J. Bhaskar; Prasad, D. Kalyan Ravi // Journal of Indian Association of Pediatric Surgeons;Oct-Dec2008, Vol. 13 Issue 4, p149 

    We report an isolated giant solid macronodular tuberculoma in an 8-year-old boy. A large-space-occupying lesion in the right lobe with nodular surface and hard consistency mimicked liver malignancy. This case is unusual as the ultrasonography, computed tomography scan, and aspiration cytology...

  • Polar Localization of Virulence-Related Esx-1 Secretion in Mycobacteria. Carlsson, Fredric; Joshi, Shilpa A.; Rangell, Linda; Brown, Eric J. // PLoS Pathogens;Jan2009, Vol. 5 Issue 1, p1 

    The Esx-1 (type VII) secretion system is critical for virulence of both Mycobacterium tuberculosis and Mycobacterium marinum, and is highly conserved between the two species. Despite its importance, there has been no direct visualization of Esx-1 secretion until now. In M. marinum, we show that...

  • Postprimary tuberculosis. Marshall, Geoffrey Brett; Babar, Judith Lynn; Müller, Nestor Luiz // CMAJ: Canadian Medical Association Journal;7/17/2007, Vol. 177 Issue 2, p148 

    The article presents a brief description and clinical appearance of postprimary tuberculosis. The disease is also called reactivation tuberculosis that develops in 5%-20% of patients infected with Mycobacterium tuberculosis. Found mainly in adults, it arises from the reactivation of bacilli that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics